m «É w «Ÿ ÉÉ É É ÉÉ É É

Size: px
Start display at page:

Download "m «É w «Ÿ ÉÉ É É ÉÉ É É"

Transcription

1 É ÉÉÉÉ ÉÉ Zacc

2 m «É w «Ÿ ÉÉ É É ÉÉ É É

3 É É É É É É É ÉÉ É Uninephrectomy induces Progressive Glomerulosclerosis and Apoptosis in Anti Thy Glomerulonephritis VEGF Gene Expression is Correlated with Glomerular Neovascularization in Human Diabetic Nephropathy VEGF Chromosomal analysis of mouse spermatozoa followinng physical and chemical treatments that are effective in inactivating HIV HIV Hypoxia Inducible Factor Involvement of cyclic AMP dependent and independent mechanisms in the relaxation of rat detrusor muscle via adrenoceptors

4 camp c erbb poly ADP ribosepolymerase Inhibition of membrane type matrix metalloproteinase MT MMPprevents the RhoA activation dependent endothelial nitric oxide synthase enosdownregulation induced by oxideized LDL LDLRhoAeNOS Comparison of expresssion pstterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development OASIS Improvement of Platelet Storage for Blood Transfusion Visual Evaluation of Fade in Response to Facial Nerve Stimulation at the Eyelid Orientation and distribution of collagen fibers in the sagittal plane of the human adult calcaneus Mastcellsasabackstayforreducingpost infarct ventricular remodeling through promotion of angiogenesis in the infarct border areas Critical threshold of nitropropionic acid induced ischemic tolerance in the rat nitropropionic acid Evaluation of a BP NCa enzyme linked immunosorbent assayelisain the initial diagnosis of bullous pemphigoid BP NCa ELISA hterthbme Galectin Myocardial strain imaging in rats: the validation and the application for therapeutic assessment in ischemic heart failure Development of subtypes of motoneurons in the cervical and thoracic spinal cord of the chick embryo É

5 w AC² ³Â É É É É É É É É É } Ù AC² ³Â É É

6 É ãw ŠnrŠe[V Š AC² ³Â É É É

7 É É É É É É É É É ÉÉ É É É ò É É ò É É É ò ò É É É É É É

8 É É É ò É É É É ò ò É É É É ò É É É É ÉÉ É

9 É É É É ^ É É É É PNH Triamcinolone acetonidea É É É DyspepsiaFunctional Dyspepsia É JMMS É RituximabBiweekly CHOP ÉÉ PhALLimatinib mesylate É PhALL É stage LLB NHL É

10 stage ALB NHL B NHL G CSF B NHLG CSF CAP KD Carbonaceous oral Adsorbent's effectiveness on Progression of chronic Kindney Disease _ XN u Zacc S t Zacc HIPÉHOPLOCK JazzHOUSE GIRL'S HIPÉHOP Zacc

11 Zacc Zacc Zacc jazz HOUSEÉBREAK'NÉHIPHOP Zacc Zacc TEL FAX

研究成果報告書

研究成果報告書 21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

More information

š ( š ) (6) 11,310, (3) 34,146, (2) 3,284, (1) 1,583, (1) 6,924, (1) 1,549, (3) 15,2

š ( š ) (6) 11,310, (3) 34,146, (2) 3,284, (1) 1,583, (1) 6,924, (1) 1,549, (3) 15,2 š ( š ) ( ) J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 13 14. 3.29 23,586,164,307 6,369,173,468 17,216,990,839 17,557,554,780 (352,062) 1,095,615,450 11,297,761,775 8,547,169,269

More information

( š ) œ 525, , , , ,000 85, , ,810 70,294 4,542,050 18,804,052 () 178,710 1,385, , ,792 72,547 80,366

( š ) œ 525, , , , ,000 85, , ,810 70,294 4,542,050 18,804,052 () 178,710 1,385, , ,792 72,547 80,366 ( š ) 557,319,095 2,606,960 31,296,746,858 7,615,089,278 2,093,641,212 6,544,698,759 936,080 3,164,967,811 20. 3.28 178,639,037 48,288,439 170,045,571 123,059,601 46,985,970 55,580,709 56,883,178 19. 4.20

More information

š ( š ) ,148,770 3,147,082 1, ,260 1,688 1,688 10,850 10, , ,

š ( š ) ,148,770 3,147,082 1, ,260 1,688 1,688 10,850 10, , , š ( š ) 60,000 240,000 120,000 60,000 120,000 360,000 72,000 1,128,000 56,380,000 14. 2.20 35,492,337 17,401,486 18,090,851 32,141,906 11,070,000 3,570,000 7,500,000 7,020,000 7,020,000 851 851 9,778,644

More information

untitled

untitled 24 591324 25 0101 0002 0101 0005 0101 0009 0101 0012 0101 0013 0101 0015 0101 0029 0101 0031 0101 0036 0101 0040 0101 0041 0101 0053 0101 0055 0101 0061 0101 0062 0101 0004 0101 0006 0101 0008 0101 0012

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

( ) g 900,000 2,000,000 5,000,000 2,200,000 1,000,000 1,500, ,000 2,500,000 1,000, , , , , , ,000 2,000,000

( ) g 900,000 2,000,000 5,000,000 2,200,000 1,000,000 1,500, ,000 2,500,000 1,000, , , , , , ,000 2,000,000 ( ) 73 10,905,238 3,853,235 295,309 1,415,972 5,340,722 2,390,603 890,603 1,500,000 1,000,000 300,000 1,500,000 49 19. 3. 1 17,172,842 3,917,488 13,255,354 10,760,078 (550) 555,000 600,000 600,000 12,100,000

More information

官報(号外第196号)

官報(号外第196号) ( ) ( ) š J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 12 13. 3.30 23,850,358,060 7,943,090,274 15,907,267,786 17,481,184,592 (354,006) 1,120,988,000 4,350,000 100,000 930,000 3,320,000

More information

body size no effect mechanical stress GH-IGF1 system + no effect? collagen production of fibroblasts + receptor + + Ia, Ib, II aldosterone renin angiotensin system Mechanical and Endocrinological

More information

Ÿ ( Ÿ ) Ÿ šœš 100,000 10,000,000 10,000,000 3,250,000 1,000,000 24,350,000 5,000,000 2,500,000 1,200,000 1,000,000 2,960,000 7,000,000 1,500,000 2,200

Ÿ ( Ÿ ) Ÿ šœš 100,000 10,000,000 10,000,000 3,250,000 1,000,000 24,350,000 5,000,000 2,500,000 1,200,000 1,000,000 2,960,000 7,000,000 1,500,000 2,200 šœ Ÿ ( Ÿ ) Ÿ 3,658,819,708 612,940,933 1,441,054,976 1,536,693,282 369,033,491 1,167,659,791 68,105,057 25,460 7,803,540,263 1,713,934,550 541,531,413 702,848,302 11,827 1,552,629,488 23,421,737,374 2,572,144,704

More information

š ( š ) ,400, , ,893, ,743, ,893, ,893, ,658,475 35,884,803 2,167,037 7,189,060 55,417,575 81,08

š ( š ) ,400, , ,893, ,743, ,893, ,893, ,658,475 35,884,803 2,167,037 7,189,060 55,417,575 81,08 Ÿ š ( š ) 1,970,400 5,000,000 12. 3.26 180,553,493 9. 9.29 41,772,995 10. 9.28 50,075,163 13. 2. 2 1,000,000 10.12.27 j 19,373,160 13. 4. 1 j 1,200,000 38. 3.19 j 1,100,000 6. 9.22 14. 1. 8 0 0 14. 3.13

More information

untitled

untitled Ÿ Ÿ ( œ ) 120,000 60,000 120,000 120,000 80,000 72,000 100,000 180,000 60,000 100,000 60,000 120,000 100,000 240,000 120,000 240,000 1,150,000 100,000 120,000 72,000 300,000 72,000 100,000 100,000 60,000

More information

研究成果報告書

研究成果報告書 系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.

More information

…_…C…L…fi…J…o†[fiü“ePDF/−mflF™ƒ

…_…C…L…fi…J…o†[fiü“ePDF/−mflF™ƒ 80 80 80 3 3 5 8 10 12 14 14 17 22 24 27 33 35 35 37 38 41 43 46 47 50 50 52 54 56 56 59 62 65 67 71 74 74 76 80 83 83 84 87 91 91 92 95 96 98 98 101 104 107 107 109 110 111 111 113 115

More information

( ) 1,771,139 54, , ,185, , , , ,000, , , , , ,000 1,000, , , ,000

( ) 1,771,139 54, , ,185, , , , ,000, , , , , ,000 1,000, , , ,000 ( ) 6,364 6,364 8,884,908 6,602,454 218,680 461,163 1,602,611 2,726,746 685,048 2,022,867 642,140 1,380,727 18,831 290,000 240,000 50 20. 3.31 11,975,755 1,215,755 10,760,000 11,258,918 (68) 160,000 500,000

More information

Ÿ ( ) Ÿ ,195,027 9,195,027 9,195, ,000 25, ,000 30,000 9,000,000 9,000, ,789, ,000 2,039,145 3,850,511 2,405,371

Ÿ ( ) Ÿ ,195,027 9,195,027 9,195, ,000 25, ,000 30,000 9,000,000 9,000, ,789, ,000 2,039,145 3,850,511 2,405,371 Ÿ ( ) Ÿ 540,000 980,000 300,000 700,000 1,200,000 1,100,000 1,300,000 980,000 400,000 220,000 280,000 400,000 300,000 220,000 1,300,000 460,000 260,000 400,000 400,000 340,000 600,000 1,500,000 740,000

More information

Ÿ Ÿ ( ) Ÿ , , , , , , ,000 39,120 31,050 30,000 1,050 52,649, ,932,131 16,182,115 94,75

Ÿ Ÿ ( ) Ÿ , , , , , , ,000 39,120 31,050 30,000 1,050 52,649, ,932,131 16,182,115 94,75 Ÿ ( ) Ÿ 100,000 200,000 60,000 60,000 600,000 100,000 120,000 60,000 120,000 60,000 120,000 120,000 120,000 120,000 120,000 1,200,000 240,000 60,000 60,000 240,000 60,000 120,000 60,000 300,000 120,000

More information

Ÿ ( ) ,166,466 18,586,390 85,580,076 88,457,360 (31) 1,750,000 83,830,000 5,000,000 78,830, ,388,808 24,568, ,480 6,507,1

Ÿ ( ) ,166,466 18,586,390 85,580,076 88,457,360 (31) 1,750,000 83,830,000 5,000,000 78,830, ,388,808 24,568, ,480 6,507,1 ( ) 60,000 120,000 1,800,000 120,000 100,000 60,000 60,000 120,000 10,000,000 120,000 120,000 120,000 120,000 1,500,000 171,209,703 5,000,000 1,000,000 200,000 10,000,000 5,000,000 4,000,000 5,000,000

More information

š ( š ) 2,973,655 3,774,545 4,719,254 1,594,319 3,011,432 1,517,982 1,493, ,503 2,591, , , , , ,000 f21 500,000 24

š ( š ) 2,973,655 3,774,545 4,719,254 1,594,319 3,011,432 1,517,982 1,493, ,503 2,591, , , , , ,000 f21 500,000 24 š ( š ) 812,488 8,633,171 390,374,410 324,279,452 9,953,269 17,329,976 2,944,796 2,944,796 6,866,917 341,279,452 12,000,000 12,000,000 2,000,000 2,000,000 1,000,000 1,000,000 500,000 600,000 I 1,000,000

More information

( ) œ œ 50, , , , ,000 f 240, ,000 f21 30,000 1,000, ,725,367 18,680,993 9,044,374 11,219,342 9,000,000 9,

( ) œ œ 50, , , , ,000 f 240, ,000 f21 30,000 1,000, ,725,367 18,680,993 9,044,374 11,219,342 9,000,000 9, ( ) œ 58,287,360 13. 4.25 15. 3.14 513,273,280 131,411,617 381,861,663 329,679,509 7,100,000 1,500,000 5,600,000 374,761,663 374,742,000 19,663 18,006,875 12,382,661 114,390 804,787 4,705,037 311,672,634

More information

Accumulation of CD8 + lymphocytes and Mƒ³ in glomeruli occurs in WRY rats after anti-gbm antibody administration. However, a role of the antibody in the leukocyte accumulation is unclear. An involvement

More information

( š ) š 13,448 1,243,000 1,249,050 1,243,000 1,243,000 1,249,050 1,249, , , ,885

( š ) š 13,448 1,243,000 1,249,050 1,243,000 1,243,000 1,249,050 1,249, , , ,885 ( š ) 7,000,000 191 191 6,697,131 5,845,828 653,450 197,853 4,787,707 577,127 4,000,000 146,580 146,580 64,000 100,000 500,000 120,000 60,000 60,000 60,000 60,000 60,000 200,000 150,000 60,000 60,000 100,000

More information

( ) œ ,475, ,037 4,230,000 4,224,310 4,230,000 4,230,000 3,362,580 2,300, , , , , , ,730 64,250 74

( ) œ ,475, ,037 4,230,000 4,224,310 4,230,000 4,230,000 3,362,580 2,300, , , , , , ,730 64,250 74 Ÿ ( ) œ 1,000,000 120,000 1,000,000 1,000,000 120,000 108,000 60,000 120,000 120,000 60,000 240,000 120,000 390,000 1,000,000 56,380,000 15. 2.13 36,350,605 3,350,431 33,000,174 20,847,460 6,910,000 2,910,000

More information

ï ñ ö ò ô ó õ ú ù n n ú ù ö ò ô ñ ó õ ï

ï ñ ö ò ô ó õ ú ù n n ú ù ö ò ô ñ ó õ ï ï ñ ö ò ô ó õ ú ù n n ú ù ö ò ô ñ ó õ ï B A C Z E ^ N U M G F Q T H L Y D V R I J [ R _ T Z S Y ^ X ] [ V \ W U D E F G H I J K O _ K W ] \ L M N X P S O P Q @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ r r @ @

More information

untitled

untitled š ( ) 200,000 100,000 180,000 60,000 100,000 60,000 120,000 100,000 240,000 120,000 120,000 240,000 100,000 120,000 72,000 300,000 72,000 100,000 100,000 60,000 120,000 60,000 100,000 100,000 60,000 200,000

More information

untitled

untitled š ( œ ) (Ÿ ) lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll J ¾ 21 22. 3.30 22,647,811,214 9,135,289,695 13,512,521,519 14,858,210,604 (438,585) 1,278,866,000 208,685,290 485,290 8,000,000

More information

untitled

untitled Ÿ ( œ ) ( ) lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll J ¾ 25 26. 3.28 19,834,572,598 5,567,519,745 14,267,052,853 13,701,344,859 (453,473) 1,293,339,800 306,707,318 306,707,318 9,096,921,367

More information

教室業績2014

教室業績2014 MFICU MFICU : - : - : -,,, : - : -- - : - : - : - - - : - - - - : - : - : - : -, : - Takano Y, Furukawa S, Ohashi M, Michikata K, Sameshima H, Ikenoue T J Obstet Gynaecol Res, : -, CTG - CTG - : - Katsuragi

More information

Juntendo Medical Journal

Juntendo Medical Journal Recent progress in nephrology Key words: rapid high elf icency dialysis, phosphate transport, plasma membrane Na+ transport, cytokine, extracellular matrix 5) Nagasawa M, Koide H, Ohsawa K, Hoshi

More information

š ( š ) 7,930,123,759 7,783,750, ,887, ,887 3,800,369 2,504,646,039 i 200,000,000 1,697,600, ,316.63fl 306,200,

š ( š ) 7,930,123,759 7,783,750, ,887, ,887 3,800,369 2,504,646,039 i 200,000,000 1,697,600, ,316.63fl 306,200, š ( š ) (Ÿ ) J lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll ¾ 907,440,279 16 17. 3.30 23,805,381,307 7,603,591,483 16,201,789,824 15,716,666,214 (400,000) 1,205,390,461 200,000,000 200,000,000

More information

1315 (15)

1315 (15) (14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide

More information

i152.j

i152.j Case 1 THE IMAGING CASES Case 2 THE IMAGING CASES Case 3 THE IMAGING CASES Case 4 THE IMAGING CASES Case 1 Reading & Diagnosis THE IMAGING CASES Case 2 Reading & Diagnosis THE IMAGING CASES Case

More information

untitled

untitled ( œ ) œ 138,800 17 171,000 60,000 16,000 252,500 405,400 24,000 22 95,800 24 46,000 16,000 16,000 273,000 19,000 10,300 57,800 1,118,408,500 1,118,299,000 109,500 102,821,836 75,895,167 244,622 3,725,214

More information

レントゲン X線

レントゲン X線 PET ( TIAN Mei ) PET 100 PET PET PET PET PET Positron Emission Tomography (PET) PET Positron Emission Tomography CT PET FDG Glucose and 18 F-FDG 18 F-FDGFDG CH3OH O CH3OH O OH OH OH OH OH OH OH 18 F *FDG

More information

官報(号外第197号)

官報(号外第197号) šÿ ( ) š 83,314,814 452,835,871 1,046,218,591 3,713,959,912 1,178,649,543 87,566,736 2,376,221,202 611,124,266 1,764,754,096 342,840 71,003,905 518,526 8,608,996,296 2,135,268,797 676,960,078 1,076,134,364

More information

untitled

untitled ( œ ) œ 2,000,000 20. 4. 1 25. 3.27 44,886,350 39,933,174 4,953,176 9,393,543 4,953,012 153,012 4,800,000 164 164 4,001,324 2,899,583 254,074 847,667 5,392,219 584,884 7,335 4,800,000 153,012 4,800,000

More information

ミニレビュー

ミニレビュー Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,

More information

š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š

š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š š š o š» p š î å ³å š š n š š š» š» š ½Ò š ˆ l ˆ š p î å ³å š î å» ³ ì š š î å š o š š ½ ñ š å š š n n å š» š m ³ n š n š p š š Ž p í š p š š» n É» š å p š n n š û o å Ì å š ˆ š š ú š p š m å ìå ½ m î

More information

untitled

untitled š ( œ ) 4,000,000 52. 9.30 j 19,373,160 13. 4. 1 j 1,400,000 15. 9.24 i 2,000,000 20. 4. 1 22. 5.31 18,914,932 6,667,668 12,247,264 13,835,519 565,000 565,000 11,677,790 11,449,790 228,000 4,474 4,474

More information

š ( ) 27,315,969 () 12,730,389 j 990,990 j 13,721,379 () 54,000,000 j 6,336,275 j 5,000,000 j 10,181,806 j 9,679,530 30,000,000 j 3,091,200 j 10,000,0

š ( ) 27,315,969 () 12,730,389 j 990,990 j 13,721,379 () 54,000,000 j 6,336,275 j 5,000,000 j 10,181,806 j 9,679,530 30,000,000 j 3,091,200 j 10,000,0 š ( ) œ 3,796,206,527 9,479,829,721 8,349,567,362 5,988,144,548 96,044,592 549,455,601 1,715,922,621 9,086,209,371 1,981,199,867 928,853,525 5,808,149,465 1,054,132,789 4,752,717,669 1,299,007 368,003,049

More information

( ) 2,335,305 5,273,357 2,428, , , , , , , ,758,734 12,834,856 15,923,878 14,404,867 3,427,064 1,287

( ) 2,335,305 5,273,357 2,428, , , , , , , ,758,734 12,834,856 15,923,878 14,404,867 3,427,064 1,287 ( ) 500,000 500,000 320,000 300,000 1,000,000 1,140,000 1,500,000 560,000 640,000 400,000 240,000 600,000 400,000 780,000 300,000 300,000 1,500,000 260,000 420,000 400,000 400,000 300,000 840,000 1,500,000

More information

研究成果報告書

研究成果報告書 21 5 28 2007 2008 CARElk CARPXR CAR CAR EST cdna CAR CAR 10FCS 96 SW480 HepG2 anti-lamin A/C anti-phospho-histone H3 anti-cyclin D1 G1 anti-cyclin A S CAR lamin A/C CAR Fig. 1 Lamin A/C /G1 lamin A/C G1

More information

第79回_プログラム.indd

第79回_プログラム.indd Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

More information

untitled

untitled 23 59 13 23 24 0101 0001 0101 0002 0101 0001 0101 0002 0101 0007 0101 0009 0101 0012 0101 0026 0101 0031 0101 0033 0101 0056 0101 0059 0101 0075 0101 0076 0101 5001 0101 0002 0101 0003 0101 0008 0101 0010

More information

( ) 3,000,000 1,437, ,003,853 9,003,853 9,003,853 9,000,000 9,000,000 3,853 3,853 8,021,583 4,000, ,302 3,670, ,270

( ) 3,000,000 1,437, ,003,853 9,003,853 9,003,853 9,000,000 9,000,000 3,853 3,853 8,021,583 4,000, ,302 3,670, ,270 ( ) 800,000 300,000 460,000 1,440,000 500,000 1,500,000 1,200,000 400,000 21 900,000 21 1,500,000 820,000 720,000 760,000 400,000 300,000 600,000 1,000,000 440,000 600,000 1,500,000 1,000,000 400,000 980,000

More information

Department of Anatomy & Developmental Biology and Centre for Neuroscience, Universiy College London Geoffrey Burnstock PURINERGIC SIGNALLING: HISTORICAL OVERVIEW AND CURRENT DEVELOPMENTS by Professor

More information

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00

9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155

More information

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

More information

( ) œ 100, ,000 4,830,000 49,500,000 10,000,000 20,000,000 (1) 11,759, ,538, ,729 11,240,000 11,034

( ) œ 100, ,000 4,830,000 49,500,000 10,000,000 20,000,000 (1) 11,759, ,538, ,729 11,240,000 11,034 Ÿ ( ) œ 0 0 15. 3.18 70,877,493 629,493 70,248,000 70,128,000 70,248,000 550,000 31,698,000 38,000,000 200,000 200,000 69,928,000 68,800,000 1,128,000 500,000 50,000 j 70,000 j 160,000 j 380,000 100,000

More information

サイトメトリー12-1.indd

サイトメトリー12-1.indd Cell Growth Inhibition and Apoptosis in Cancer Cells Kazuki Omoteyama, Shoichi Inoue and Alaa-eldin Salah-eldin Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth

More information

薬 理 学 教 室

薬 理 学 教 室 業績目録 ( 平成 22 年 ) (B-a) 英文総説 1) Fan C, Katsuyama M, Wei H, Xia Q, Liu W, Yabe-Nishimura C. Molecular Mechanisms Underlying PGF2alpha-induced Hypertrophy of Vascular Smooth Muscle Cells. Yakugaku Zasshi

More information

計算機生命科学の基礎II_

計算機生命科学の基礎II_ Ⅱ 1.4 atsushi_doi@cell-innovator.com 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/

More information

untitled

untitled Japan College of Social Work 01 Japan College of Social Work Profile Contents Japan College of Social Work 02 01 Case 02 Case 03 Case 04 Case 05 Case 03 Japan College of Social Work Japan College of Social

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

untitled

untitled š ( ) 300,000 180,000 100,000 120,000 60,000 120,000 240,000 120,000 170,000 240,000 100,000 99,000 120,000 72,000 100,000 450,000 72,000 60,000 100,000 100,000 60,000 60,000 100,000 200,000 60,000 124,000

More information

ê ê ê 2007 ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê b b b b b b b b b b b ê ê ê b b b b ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê ê b

More information

65-6 小泉・谷所・野村・楠本.pwd

65-6 小泉・谷所・野村・楠本.pwd CSA p r p r 5N 20N 5N 10N 15N 20N Komiya et al 0kgf 25 kgf MRI 50M 171.1 5.15 cm, 64.3 7.78 kg, 26.13 1.420 cm Oldfield The Edinburgh Inventory LEFT RIGHT RIGHT RIGHT LEFT LEFT RIGHT Oldfield Laterality

More information

untitled

untitled œ ( œ ) œ 847,120 2,343,446 2,343,446 45,242 25. 5.17 6,472,966 6,472,966 6,472,966 972,332 972,332 5,500,000 5,500,000 634 634 2,053,480 1,423,820 27,053 79,255 523,352 4,419,486 95,352 4,300,204 4,300,204

More information

ALDEFLUOR® 造血幹細胞/造血前駆細胞の新しい同定試薬

ALDEFLUOR® 造血幹細胞/造血前駆細胞の新しい同定試薬 ALDEFLUOR Immunophenotyping ALDEFLUOR Primitive Mature or ALDH Aldehyde Dehydrogenase(ALDH) ALDH Stemness ALDH Primitive Mature ALDEFLUOR Intracellular enzymatic assay ALDEFLUOR BAAA ALDH BAA ALDH BAA

More information

untitled

untitled RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3

More information

.w..01 (1-14)

.w..01 (1-14) ISSN 0386-7617 Annual Research Reports No.33, 2009 THE FOUNDATION FOR GROWTH SCIENCE ön é

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

untitled

untitled ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504

More information

LL 2

LL 2 1 LL 2 100 1990 3 4 í().. 1986 1992.. 5 õ?? / / / /=/ / / Ì / 77/ / / / / / / ûý7/..... /////////////Ì 7/ / 7/ / / / / ûý7/..... / / / / / / / / Ì / Í/ / / / / / / / / ûý7/.. / : Ì / Í/ / / / / / / / /

More information

The Effect of the Circumferential Temperature Change on the Change in the Strain Energy of Carbon Steel during the Rotatory Bending Fatigue Test by Ch

The Effect of the Circumferential Temperature Change on the Change in the Strain Energy of Carbon Steel during the Rotatory Bending Fatigue Test by Ch The Effect of the Circumferential Temperature Change on the Change in the Strain Energy of Carbon Steel during the Rotatory Bending Fatigue Test by Chikara MINAMISAWA, Nozomu AOKI (Department of Mechanical

More information

untitled

untitled š ( ) œ 1 1,128,321 24,000 3,347 359,874 741,100 5,519,882 1,863,153 10,000 10,000 10,000 36,729 3,600,000 107,000 33,749,250 24. 5.29 1,518,131 18,131 1,500,000 1,511,729 1,500,000 1,500,000 769,268 100,000

More information